GU Cancers 2023 | Which populations should be screened for prostate cancer?

David M. Nanus, MD, Weill Cornell Medicine and New York Presbyterian Hospital, New York City, NY, discusses which populations are at high risk of prostate cancer and who would therefore benefit most from screening. Dr Nanus also discusses increase awareness and participation in screening programmes. This interview took place at the ASCO GU Cancers Symposium 2023 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.